REQUEST A DEMO
Total
USD $0.00
Search more companies

Obio Technology (Shanghai) Corp.,Ltd. (China)

Main Activities: Pharmaceutical and Medicine Manufacturing | Scientific Research and Development Services
Full name: Obio Technology (Shanghai) Corp.,Ltd. Profile Updated: April 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Obio Technology (Shanghai) Corp., Ltd. is a biotechnology company focusing on the field of gene therapy. It is engaged in providing CRO services such as gene therapy vector development, gene function research, drug target and drug efficacy research for basic gene therapy research. It provides CDMO services such as process development and testing, IND-CMC pharmaceutical research, and clinical sample GMP production for the research and development of genetic drugs. The company was founded in 2013, and headquartered in Shanghai City, China.

Headquarters
Building 19, Lane 908, Ziping Road, Pudong New District, Shanghai City
Shanghai; Shanghai; Postal Code: 201318

Contact Details: Purchase the Obio Technology (Shanghai) Corp.,Ltd. report to view the information.

Website: http://www.obiosh.com

Basic Information
Total Employees:
Purchase the Obio Technology (Shanghai) Corp.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Obio Technology (Shanghai) Corp.,Ltd. report to view the information.
Registered Capital:
Purchase the Obio Technology (Shanghai) Corp.,Ltd. report to view the information.
Financial Auditors:
Purchase the Obio Technology (Shanghai) Corp.,Ltd. report to view the information.
Incorporation Date:
March 05, 2013
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
18.97%
Purchase this report to view the information.
5.42%
Purchase this report to view the information.
3.58%
Purchase this report to view the information.
3.07%
Purchase this report to view the information.
3.03%
Subsidiaries
Heyuan Biotechnology (Usa) Co., Ltd.
100%
Heyuan Intelligent Manufacturing (Shanghai) Gene Technology Co., Ltd.
100%
Heyuan Nuen (Shanghai) Biotechnology Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Obio Technology (Shanghai) Corp.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
93.48%
Total operating revenue
93.49%
Operating profit (EBIT)
-56.76%
EBITDA
-53.15%
Net Profit (Loss) for the Period
-32.99%
Total assets
2.54%
Total equity
-5.89%
Operating Profit Margin (ROS)
20.03%
Net Profit Margin
32.3%
Return on Equity (ROE)
-0.62%
Debt to Equity Ratio
3.46%
Quick Ratio
-6.81%
Cash Ratio
-6.11%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?